| Name | ECO Animal Health Group |
|---|---|
| Epic | EAH |
| Isin | GB0032036807 |
| Industry | Pharmaceuticals & Biotechnology |
| Latest share price | 62.50p | Net gearing | n/a |
|---|---|---|---|
| Market capitalisation | £42.35 | Debt ratio | n/a |
| Shares in issue | 67.76 | Debt-to-equity ratio | n/a |
| P/E ratio | 55.2 | Assets / equity ratio | n/a |
| Total dividends per share | n/a | Price to book value | n/a |
| Dividend yield | n/a | ROCE | 7.21 |
| Dividend cover | n/a | EPS growth | 4 |
| Earning per share | 1.55 | 52-week high / low | 62.00p / 131.50p |
| Type | Ex-date | Pay-date | Net-dividend |
|---|---|---|---|
| Final | 2021-09-23 | 2021-10-22 | 1.00p |
| Company name | ECO Animal Health Group |
|---|---|
| Address | The Grange, 100 High street, London, United Kingdom, N14 6BN |
| Telephone | +44 (0) 208 336 2900 |
| Website | http://www.ecoanimalhealthgroupplc.com/ |
| Director | Position |
|---|---|
| Mr David Hallas | CEO |
| Mr Christopher Wilks | CFO |
| Ms Tracey James | Non-Executive Director |
| Dr Frank Armstrong | Non-Executive Director |
| Mr Dr. Joachim Hasenmaier | Non-Executive Director |
| Dr Andrew Jones | Non-Executive Chairman |
| Assets £ (m) | 2024 | 2023 | 2022 |
|---|---|---|---|
| Reporting date | 31/03/24 | 31/03/23 | 31/03/22 |
| Intangible asssets and goodwill | 38.35 | 35.64 | 34.3 |
| Investments and other non-current assets | 0.27 | 0.25 | 0.21 |
| Total non-current assets | 48.53 | 46.83 | 40.5 |
| Inventory / work in progress | 16.95 | 22.41 | 30.14 |
| Trade and other receivables | 32.17 | 26.85 | 25.97 |
| Cash and equivalents | 22.37 | 21.66 | 14.31 |
| Other current assets and asset held for resale | 3.23 | 3.57 | 2.67 |
| Total of all assets | 123.27 | 121.31 | 113.6 |
| Liabilities £ (m) | 2024 | 2023 | 2022 |
|---|---|---|---|
| Short term liabilities | 25.23 | 22.17 | 17.74 |
| Long term liabilities | 4.66 | 3.6 | 1.51 |
| Other liabilites / pension etc | n/a | n/a | n/a |
| Total of all liabilities | 29.89 | 25.76 | 19.25 |
| Net assets £ (m) | 2024 | 2023 | 2022 |
|---|---|---|---|
| Net assets | 93.38 | 95.55 | 94.35 |
| Equity £ (m) | 2024 | 2023 | 2022 |
|---|---|---|---|
| Share capital | 3.39 | 3.38 | 3.38 |
| Minority interests | 9.69 | 12.28 | 12.28 |
| Retained earnings | 15.82 | 13.93 | 12.41 |
| Share premium account | 63.32 | 63.32 | 63.32 |
| Total equity | 93.38 | 95.55 | 94.35 |
| Income £ (m) | 2024 | 2023 | 2022 |
|---|---|---|---|
| Turnover | n/a | n/a | n/a |
| Operating profit | 3.54 | 4.95 | 1.44 |
| Pre-tax profit | 3.74 | 5.1 | 1.39 |